From : Brenda Killen <bkillen@gavi.org>
To : aalkhal@hamad.qa; akilah.byron-nisbett@gov.kn; alexandra.galea@gov.mt; allison.jones@health.gov.au; covid19vaccinetaskforce@health.gov.au; secmin.volksgerondheid@gov.sr; andrej.vujkovac@gmail.com; anita.sohan@health.gov.tt; psmoh@health.gov.tt; Anne Weber <anne.weber@mae.etat.lu>; anneli.veisson@mfa.ee; arnaldo.medeiros@saude.gov.br; ministro@saude.gov.br; athaliah@almolokomme.com; botgen@bluewin.ch; aportocarrero@minsa.gob.pe; baderalrawahi4@gmail.com; ben.nangombe@mhss.gov.na; bnangombe@gmail.com; bernhard.fattinger@bmeia.gv.at; bogdan.kirilov@bda.bg; cmakriyiannis@mfa.gov.cy; dace.cildermane@mfa.gov.lv; dalbastaki@moh.gov.kw; evoiglio@gouv.mc; falhosani@adphc.gov.ae; francisco.adriazola@minsal.cl; falaggia@msp.gub.uy; gaafar.uherbelau@palauhealth.org; gerry_obrien@health.gov.ie; gerbir@um.dk; guilherme.gduarte@mne.pt; hh.meijer@minvws.nl; head_erpmb@dh.gov.hk; ioberrio@minsa.gob.pa; mckenziej@moh.gov.jm; javier.salido@maec.es; jchou@cdc.gov.tw; taiwancdc@cdc.gov.tw; joan.valadou@diplomatie.gouv.fr; secretariat.dgm-ddd-huma@diplomatie.gouv.fr; john-arne.rottingen@mfa.no; kaisa.lahdepuro@stm.fi; tagupon@hotmail.com; doctor.kieran.keke@gmail.com; iamc@ssm.gov.mo; lnanushyan@moh.am; lucy.duncan@mfat.govt.nz; maria.sarafian@romaniaunog.org; m.barragan@eib.org; mdelgadop@sre.gob.mx; or-mx-corona-l@auswaertiges-amt.de; mmonsalvo@msal.gov.ar; melissa.sutherland2@canada.ca; michelangelo.nerini@esteri.it; miguel.ceballos-baron@ec.europa.eu; miklos.gaal@mfa.gov.hu; hrdinkova.milena@vlada.cz; mohsen.asadi@yahoo.com; nikica.darabos@mvep.hr; nora.kronig@bag.admin.ch; oscar.ekeus@gov.se; pieter.vermaerke@diplobel.fed.be; rkolsoe@mfa.is; randa_ham@hotmail.com; riyadalhilfi@gmail.com; robertas.rosinas@urm.lt; ronaldo.estrada@mspas.gob.gt; slavica.milacic@mfa.gov.me; sorayaraya@gmail.com; dr_abusrewil@yahoo.co.uk; agardt@gov.ms; chorhchuan.tan@moht.com.sg; tan_chorh_chuan@moh.gov.sg; tim.colley@beis.gov.uk; uri.feinstein@moh.gov.il; mishpatit@moh.gov.il; udcanabady@govmu.org; verica_jovanovic@batut.org.rs; wailh@yahoo.com; xavier.solorzano@msp.gob.ec; convocatorias.despacho@msp.gob.ec; chinamission_gva@mfa.gov.cn; morningcalm@korea.kr; zmemish@yahoo.com; costesr@moh.gov.sa; polio@ncdc.ge
Subject : RE: COVAX Shareholders Council, Thursday 18 March, 13.00-15.00 CET - Materials and Logistics
Cc : nuno.simoes@infarmed.pt; paula.pereira@camoes.mne.pt; internacionalesmpps@gmail.com; despachompps2020@gmail.com; Omar Abdi <oaabdi@unicef.org>; Etleva Kadilli <ekadilli@unicef.org>; Benjamin Schreiber <bschreiber@unicef.org>; Dr Zsuzsanna Jakab <jakabz@who.int>; O'BRIEN, Katherine <obrienk@who.int>; Lidija Kamara - WHO <kamaral@who.int>; mpate <mpate@worldbank.org>; Michael Kent Ranson <mranson@worldbank.org>; Diane Wu <dwu3@worldbank.org>; Clementine Laurence Murer <cmurer@worldbank.org>; barbosajar@paho.org; Maty Dia <mwdia@pai.org>; rafael.vilasanjuan@isglobal.org; Amy Whalley <amywhalley01@gmail.com>; lia.tadesse@moh.gov.et; Muluken Desta <mulukenaleka2@gmail.com>; Dr. Daniel Gebremichael <daniel.gebremichael@moh.gov.et>; setmenlu@kemlu.go.id; Grata Endah Werdaningtyas <grata.endahw@mission-indonesia.org>; Meutia H. Hasan <meutia.hasan@mission-indonesia.org>; Executive Team <ExecutiveTeam@gavi.org>; Executive Team Assistants <ExecutiveTeamAssistants@gavi.org>; Governance Staff <Governance@gavi.org>; Executive Office Staff <ExecutiveOfficeStaff@gavi.org>; COVAX Facility Leadership team <covaxfacilityleadershipteam@Gavi.org>; COVAX Facility <covax@Gavi.org>; Daniel Thornton <dthornton@gavi.org>; Sam Muller <smuller@gavi.org>; Gloria Kebirungi <gkebirungi@worldbank.org>; Carmen Tull <ctull@usaid.gov>; enoonan@usaid.gov; silviabino@gmail.com; nejsi.lleshi@shendetesia.gov.al; cmoantigua@gmail.com; jeniece.stromain@ab.gov.ag; apaaquino@gmail.com; cmoretti@msal.gov.ar; Niamh.Dobson@dfat.gov.au; Patrick.Reynolds@health.gov.au; andrew.rintoul@health.gov.au; v.samir@outlook.com; Dusan.Kojic@mcp.gov.ba; Kamelia.Petrova@mfa.bg; chase.mcgowan@canada.ca; tammy.Bunbury@international.gc.ca; movargas@rree.go.cr; Corinna.hulnhagen@eeas.europa.eu; canice.nolan@eeas.europa.eu; r.cordiner@eib.org; edgar.tilly@dgtresor.gouv.fr; Joan.valadou@diplomatie.gouv.fr; tgabunia@moh.gov.ge; aslaug.einarsdottir@hrn.is; mgouya57@gmail.com; hs.safavi@gmail.com; Riyadalhilfi@gmail.com; unagencies@geneva.mfa.gov.il; LIRON.ZOHAR@MOH.GOV.IL; melodyennis5@gmail.com; williamsn@moh.gov.jm; okubo-takayuki@mhlw.go.jp; mami.wakabayashi@mofa.go.jp; secretg@korea.kr; ayeon29@korea.kr; malcantaraa@sre.gob.mx; stuart.dymond@mfat.govt.nz; Lene Lothe <lene.lothe@norad.no>; kristine.husoy.onarheim@mfa.no; teo_junxiong@moh.gov.sg; sharon_ling@moh.gov.sg; Amy Whalley <amywhalley01@gmail.com>; auroramaria.danese@bag.admin.ch; martina.schwab@bag.admin.ch; cym@cdc.gov.tw; yuchen@cdc.gov.tw; Gian Gandhi <ggandhi@unicef.org>; Dorcas Noertoft <dnoertoft@unicef.org>; tprasad@unicef.org; Dylan.Bruce@beis.gov.uk; saul.walker@fcdo.gov.uk; asuntosinternacionales.mpps@gmail.com; mmartint@gmail.com; Chiloyan@bu.edu; Bernhard.FATTINGER@bmeia.gv.at; Gamze.subasi@bmeia.gv.at; boitau04@gmail.com; elis.guedes@saude.gov.br; aai@saude.gov.br; bogdan.kirilov@bda.bg; Nikica.darabos@mvep.hr; cmakriyiannis@mfa.gov.cy; hrdinkova.milena@vlada.cz; Kristyna.Kralova@mzcr.cz; githun@um.dk; GERBIR@UM.DK; jenskv@um.dk; narcisa.calahorrano@msp.gob.ec; felipe.illingworth@msp.gob.ec; fernando.jacome@msp.gob.ec; Anneli.Veisson@mfa.ee; kaisa.lahdepuro@stm.fi; Assietou Diouf <adiouf@gavi.org>; Ian MacTavish (Consultant) <imactavish@gavi.org>; Thabani Maphosa <tmaphosa@gavi.org>; sanne.wendes@gmail.com; or-mx-corona-l@auswaertiges-amt.de; wi-1-io@genf.diplo.de; king_ho_tang@dh.gov.hk; charlottachak@dh.gov.hk; ro3_ere@dh.gov.hk; ymlau@dh.gov.hk; miklos.gaal@mfa.gov.hu; geneva@mission-indonesia.org; fergal.horgan@dfa.ie; gerry_obrien@health.gov.ie; michelangelo.nerini@esteri.it; Signe.Bokta@vmnvd.gov.lv; Dace.Cildermane@mfa.gov.lv; liga.timsa@vm.gov.lv; robertas.rosinas@urm.lt; Anne Weber <anne.weber@mae.etat.lu>; alexandra.galea@gov.mt; sarah.spronk@minbuza.nl; kdaryanani@minsa.gob.pa; tnoriega@minsa.gob.pa; ihslocum@minsa.gob.pa; guilherme.gduarte@mne.pt; maria.sarafian@romaniaunog.org; gabriela.svecova@health.gov.sk; elena.jablonicka@gmail.com; andrej.vujkovac@gmail.com; Klemen.ponikvar@gov.si; scuesta@presidencia.gob.es; ander.ruizdegopegui@maec.es; javier.salido@maec.es; oscar.ekeus@gov.se; hh.meijer@minvws.nl; ggomez@msp.gub.uy; tpicon@msp.gub.uy; vpiriz@msp.gub.uy; nejsi.lleshi@shendetesia.gov.al; silviabino@gmail.com; cmoantigua@gmail.com; internacionales@msal.gov.ar; moretti.carlaandrea@gmail.com; diana.lalazaryan@moh.am; COVID19VaccineTaskforce@health.gov.au; Andrew.Rintoul@health.gov.au; info@its.gov.az; PrenellKing_Rolle@Bahamas.gov.bs; aysha.adel@bdfmedical.org; pshealth@health.gov.bb; jsabido@health.gov.bz; swashington@gov.bm; aooyinloye@gov.bm; Kabinet.ministra@mcp.gov.ba; Dusan.Kojic@mcp.gov.ba; aai@saude.gov.br; ministro@saude.gov.br; TOFlaherty@gov.vg; levent.ozmutlu@tpsgc-pwgsc.gc.ca; john.lee@gov.ky; cecilia.ganzalez@minsal.cl; zhuanmenzu@gmail.com; adriana.jimenez@gestiondelriesgo.gov.co; lina.martinez@gestiondelriesgo.gov.co; correspondencia.ministo@misalud.go.cr; medelcastillo@gmail.com; Juan.zevallos@msp.gob.ec; convocatorias.despacho@msp.gob.ec; fernando.jacome@msp.gob.ec; Jan.PAEHLER@ec.europa.eu; r.cordiner@eib.org; tgabunia@moh.gov.ge; info@moh.gov.ge; a.gamkrelidze@ncdc.ge; ronaldo.estrada@mspas.gob.gt; ymlau@dh.gov.hk; aslaug.einarsdottir@hrn.is; anna.gunnarsdottir@utn.is; mohsen.asadi@yahoo.com; firas_tuqa@yahoo.com; Vadim.Perman@moh.gov.il; mishpatit@moh.gov.il; mankal@moh.gov.il; palmerr@moh.gov.jm; mckenxiej@moh.gov.jm; okubo-takayuki@mhlw.go.jp; makiko.yoneda@mofa.go.jp; minister.office@moh.gov.jo; a.albader@moh.gov.kw; lmb@lmb.ly; dallagapen@govmu.org; jorge.alcocer@salud.gon.mx; dlanzara@gouv.mc; kabinet@mzd.gov.me; AgardT@gov.ms; staceycain7@gmail.com; garabwanc@gmail.com; Stuart.Dymond@mfat.govt.nz; glenys.karran@mfat.govt.nz; Lene Lothe <lene.lothe@norad.no>; minister.office@moh.gov.om; gaafar.uherbelau@palauhealth.org; tnoriega@minsa.gob.pa; lsuarez@minsa.gob.pe; Aalansari4@moph.gov.qa; tjkim19@mofa.go.kr; zmemish@ksmc.med.sa; kabinet@zdravlke.gov.rs; TEO_Junxiong@moh.gov.sg; hazel.laws@gov.kn; secmin.volksgezondheid@gov.sr; taiwancdc@cdc.gov.tw; psmoh@health.gov.tt; DLewis@gov.tc; ehill@mubadala.ae; adillon@mubadala.ae; Emma.Gillespie@beis.gov.uk; kristine.husoy.onarheim@mfa.no; anja.sletten@norad.no
Received On : 17.03.2021 20:55
Attachments :

Dear Shareholders Council Members

 

We are pleased to confirm that the pre-read for the meeting is now available in Arabic, French, Russian and Spanish on BoardEffect at https://gavi.boardeffect.co.uk/workrooms/14276/books/10056836.

 

Regards

 

Brenda

 

From: Brenda Killen
Sent: 11 March 2021 23:05
To: Gelardina.Prodani@shendetesia.gov.al; joanmartinezbenazet@govern.ad; Cordella.weston@ab.gov.ag; internacionales@msal.gov.ar; lnanushyan@moh.am; Allison.Jones@health.gov.au; faliyeva@tabib.gov.az; delonbrennen@bahamas.gov.bs; yaser.sakheer@bdfmedical.org; pshealth@health.gov.bb; jsabido@health.gov.bz; aooyinloye@gov.bm; ankica.gudeljevic@mcp.gov.ba; Boitau04@gmail.com; arnaldo.medeiros@saude.gov.br; TOFlaherty@gov.vg; zulaidi.latif@moh.gov.bn; melissa.sutherland2@canada.ca; john.lee@gov.ky; dgarcia@subrei.gob.cl; mryongfeng@gmail.com; larregoces@minsalud.gov.co; roberto.arroba@misalud.go.cr; indhira.guillen@ministeriodesalud.gob.do; xavier.solorzano@msp.gob.ec; miguel.ceballos-baron@ec.europa.eu; m.barragan@eib.org; ljabidze@gmail.com; ronaldo.estrada@mspas.gob.gt; head_erpmb@dh.gov.hk; rkolsoe@mfa.is; mohsen.asadi@yahoo.com; riyadalhilfi@gmail.com; uri.feinstein@moh.gov.il; mckenziej@moh.gov.jm; tagupon@hotmail.com; wailh@yahoo.com; dalbastaki@moh.gov.kw; randa_ham@hotmail.com; dr_abusrewil@yahoo.co.uk; Iamc@ssm.gov.mo; udcanabady@govmu.org; mdelgadop@sre.gob.mx; evoiglio@gouv.mc; slavica.milacic@mfa.gov.me; AgardT@gov.ms; doctor.kieran.keke@gmail.com; lucy.duncan@mfat.govt.nz; John-Arne.Rottingen@mfa.no; baderalrawahi4@gmail.com; gaafar.uherbelau@palauhealth.org; ioberrio@minsa.gob.pa; sorayaraya@gmail.com; ccastillos@minsa.gob.pe; aalkhal@hamad.qa; byuly74@korea.kr; zmemish@yahoo.com; verica_jovanovic@batut.org.rs; tan_chorh_chuan@moh.gov.sg; akilah.byron-nisbett@gov.kn; secmin.volksgerondheid@gov.sr; nora.kronig@bag.admin.ch; jchou@cdc.gov.tw; anita.sohan@health.gov.tt; amorgan@gov.tc; falhosani@adphc.gov.ae; tim.colley@beis.gov.uk; falaggia@msp.gub.uy
Cc: nuno.simoes@infarmed.pt; paula.pereira@camoes.mne.pt; internacionalesmpps@gmail.com; despachompps2020@gmail.com; Omar Abdi ; Etleva Kadilli ; Benjamin Schreiber ; Dr Zsuzsanna Jakab ; O'BRIEN, Katherine ; Lidija Kamara - WHO ; mpate ; Michael Kent Ranson ; Diane Wu ; Clementine Laurence Murer ; barbosajar@paho.org; Maty Dia ; rafael.vilasanjuan@isglobal.org; Amy Whalley ; lia.tadesse@moh.gov.et; Muluken Desta ; Dr. Daniel Gebremichael ; setmenlu@kemlu.go.id; Grata Endah Werdaningtyas ; Meutia H. Hasan ; Executive Team ; Executive Team Assistants ; Governance Staff ; Executive Office Staff ; COVAX Facility Leadership team ; COVAX Facility ; Daniel Thornton ; Sam Muller ; Gloria Kebirungi ; Carmen Tull ; enoonan@usaid.gov; silviabino@gmail.com; nejsi.lleshi@shendetesia.gov.al; cmoantigua@gmail.com; jeniece.stromain@ab.gov.ag; apaaquino@gmail.com; cmoretti@msal.gov.ar; Niamh.Dobson@dfat.gov.au; Patrick.Reynolds@health.gov.au; andrew.rintoul@health.gov.au; v.samir@outlook.com; Dusan.Kojic@mcp.gov.ba; Kamelia.Petrova@mfa.bg; chase.mcgowan@canada.ca; tammy.Bunbury@international.gc.ca; movargas@rree.go.cr; Corinna.hulnhagen@eeas.europa.eu; canice.nolan@eeas.europa.eu; r.cordiner@eib.org; edgar.tilly@dgtresor.gouv.fr; Joan.valadou@diplomatie.gouv.fr; tgabunia@moh.gov.ge; aslaug.einarsdottir@hrn.is; mgouya57@gmail.com; hs.safavi@gmail.com; Riyadalhilfi@gmail.com; unagencies@geneva.mfa.gov.il; LIRON.ZOHAR@MOH.GOV.IL; melodyennis5@gmail.com; williamsn@moh.gov.jm; okubo-takayuki@mhlw.go.jp; mami.wakabayashi@mofa.go.jp; secretg@korea.kr; ayeon29@korea.kr; malcantaraa@sre.gob.mx; stuart.dymond@mfat.govt.nz; Lene Lothe ; kristine.husoy.onarheim@mfa.no; teo_junxiong@moh.gov.sg; sharon_ling@moh.gov.sg; Amy Whalley ; auroramaria.danese@bag.admin.ch; martina.schwab@bag.admin.ch; cym@cdc.gov.tw; yuchen@cdc.gov.tw; Gian Gandhi ; Dorcas Noertoft ; tprasad@unicef.org; Dylan.Bruce@beis.gov.uk; saul.walker@fcdo.gov.uk; asuntosinternacionales.mpps@gmail.com; mmartint@gmail.com; Chiloyan@bu.edu; Bernhard.FATTINGER@bmeia.gv.at; Gamze.subasi@bmeia.gv.at; boitau04@gmail.com; elis.guedes@saude.gov.br; aai@saude.gov.br; bogdan.kirilov@bda.bg; Nikica.darabos@mvep.hr; cmakriyiannis@mfa.gov.cy; hrdinkova.milena@vlada.cz; Kristyna.Kralova@mzcr.cz; githun@um.dk; GERBIR@UM.DK; jenskv@um.dk; narcisa.calahorrano@msp.gob.ec; felipe.illingworth@msp.gob.ec; fernando.jacome@msp.gob.ec; Anneli.Veisson@mfa.ee; kaisa.lahdepuro@stm.fi; Assietou Diouf ; Ian MacTavish (Consultant) ; Thabani Maphosa ; sanne.wendes@gmail.com; or-mx-corona-l@auswaertiges-amt.de; wi-1-io@genf.diplo.de; king_ho_tang@dh.gov.hk; charlottachak@dh.gov.hk; ro3_ere@dh.gov.hk; ymlau@dh.gov.hk; miklos.gaal@mfa.gov.hu; geneva@mission-indonesia.org; fergal.horgan@dfa.ie; gerry_obrien@health.gov.ie; michelangelo.nerini@esteri.it; Signe.Bokta@vmnvd.gov.lv; Dace.Cildermane@mfa.gov.lv; liga.timsa@vm.gov.lv; robertas.rosinas@urm.lt; Anne Weber ; alexandra.galea@gov.mt; sarah.spronk@minbuza.nl; kdaryanani@minsa.gob.pa; tnoriega@minsa.gob.pa; ihslocum@minsa.gob.pa; guilherme.gduarte@mne.pt; maria.sarafian@romaniaunog.org; gabriela.svecova@health.gov.sk; elena.jablonicka@gmail.com; andrej.vujkovac@gmail.com; Klemen.ponikvar@gov.si; scuesta@presidencia.gob.es; ander.ruizdegopegui@maec.es; javier.salido@maec.es; oscar.ekeus@gov.se; hh.meijer@minvws.nl; ggomez@msp.gub.uy; tpicon@msp.gub.uy; vpiriz@msp.gub.uy; nejsi.lleshi@shendetesia.gov.al; silviabino@gmail.com; cmoantigua@gmail.com; internacionales@msal.gov.ar; moretti.carlaandrea@gmail.com; diana.lalazaryan@moh.am; COVID19VaccineTaskforce@health.gov.au; Andrew.Rintoul@health.gov.au; info@its.gov.az; PrenellKing_Rolle@Bahamas.gov.bs; aysha.adel@bdfmedical.org; pshealth@health.gov.bb; jsabido@health.gov.bz; swashington@gov.bm; aooyinloye@gov.bm; Kabinet.ministra@mcp.gov.ba; Dusan.Kojic@mcp.gov.ba; aai@saude.gov.br; ministro@saude.gov.br; TOFlaherty@gov.vg; levent.ozmutlu@tpsgc-pwgsc.gc.ca; john.lee@gov.ky; cecilia.ganzalez@minsal.cl; zhuanmenzu@gmail.com; adriana.jimenez@gestiondelriesgo.gov.co; lina.martinez@gestiondelriesgo.gov.co; correspondencia.ministo@misalud.go.cr; medelcastillo@gmail.com; Juan.zevallos@msp.gob.ec; convocatorias.despacho@msp.gob.ec; fernando.jacome@msp.gob.ec; Jan.PAEHLER@ec.europa.eu; r.cordiner@eib.org; tgabunia@moh.gov.ge; info@moh.gov.ge; a.gamkrelidze@ncdc.ge; ronaldo.estrada@mspas.gob.gt; ymlau@dh.gov.hk; aslaug.einarsdottir@hrn.is; anna.gunnarsdottir@utn.is; mohsen.asadi@yahoo.com; firas_tuqa@yahoo.com; Vadim.Perman@moh.gov.il; mishpatit@moh.gov.il; mankal@moh.gov.il; palmerr@moh.gov.jm; mckenxiej@moh.gov.jm; okubo-takayuki@mhlw.go.jp; makiko.yoneda@mofa.go.jp; minister.office@moh.gov.jo; a.albader@moh.gov.kw; lmb@lmb.ly; dallagapen@govmu.org; jorge.alcocer@salud.gon.mx; dlanzara@gouv.mc; kabinet@mzd.gov.me; AgardT@gov.ms; staceycain7@gmail.com; garabwanc@gmail.com; Stuart.Dymond@mfat.govt.nz; glenys.karran@mfat.govt.nz; Lene Lothe ; minister.office@moh.gov.om; gaafar.uherbelau@palauhealth.org; tnoriega@minsa.gob.pa; lsuarez@minsa.gob.pe; Aalansari4@moph.gov.qa; tjkim19@mofa.go.kr; zmemish@ksmc.med.sa; kabinet@zdravlke.gov.rs; TEO_Junxiong@moh.gov.sg; hazel.laws@gov.kn; secmin.volksgezondheid@gov.sr; taiwancdc@cdc.gov.tw; psmoh@health.gov.tt; DLewis@gov.tc; ehill@mubadala.ae; adillon@mubadala.ae; Emma.Gillespie@beis.gov.uk; kristine.husoy.onarheim@mfa.no; anja.sletten@norad.no
Subject: COVAX Shareholders Council, Thursday 18 March, 13.00-15.00 CET - Materials and Logistics

 

Dear Shareholders Council Members

 

I am pleased to confirm that the pre-read for the meeting of the COVAX Shareholders Council which will take place on Thursday 18 March from 13.00 to 15.00 Geneva time, is now available for you to consult and download on BoardEffect at https://gavi.boardeffect.co.uk/workrooms/14276/books/10056836

 

We would kindly request that you share the materials within your country/economy/organisation/constituency as appropriate, as per the information I shared with you in relation to the BoardEffect platform earlier today.

 

In respect of Agenda Item 3, the latest COVAX supply forecasts are available here: https://www.gavi.org/sites/default/files/covid/covax/COVAX%20Supply%20Forecast.pdf. We will share the most up-to-date picture during our meeting given the quickly evolving nature of the portfolio.

 

The pre-read materials are being translated into Arabic, French, Russian and Spanish and we hope to be able to share the translated materials with all participants by Wednesday 17 March.

 

Les documents sont en cours de traduction en arabe, français, russe et espagnol et nous espérons pouvoir partager les documents traduits avec tous les participants le mercredi 17 mars.

 

Los materiales se están traduciendo al árabe, francés, ruso y español y esperamos poder compartir los materiales traducidos con todos los participantes, el miercoles 17 de marzo.

 

В данный момент материалы переводятся на арабский, французский, русский и испанский языки, и мы надеемся, что сможем их предоставить всем участникам завтра, в  среду 17 марта.

 

تتم ترجمة المواد إلى العربية والفرنسية والروسية والإسبانية ونأمل أن نتمكن من مشاركة المواد المترجمة مع جميع المشاركين

يوم الأربعاء 17 مارس.

 

As indicated in previous correspondence we will be using the Zoom platform for the meeting. 

 

Our “Guidelines for Meeting of COVAX Shareholders Council – March 2021” (attached) contain important information in relation to the following:

 

  1. Setting up the Zoom application
  2. Setting up the interpretation
  3. Connecting to the meeting
  4. Taking part in discussions during the meeting

 

Zoom application – it is recommended that participants join the meeting using a computer and download the meeting application well in advance of the meeting so as to enable any potential technical issues to be resolved in a timely manner.

                                                                                                                                                                            

All participants will receive a Zoom webinar invitation via email which will contain a link to join the meeting. The invitation, which will normally be sent out on Monday 15 March, will come from COVAX Shareholders Council Meeting (no-reply@zoom.us)Please note that for the security of the meeting, links are individual and non-transferable.

 

For any technical assistance before or during the meeting, kindly contact covax.event@gavi.org.

 

Should you have any other questions please do not hesitate to contact either Joanne Goetz, Head, Governance (jgoetz@gavi.org) or myself. 

 

Regards

 

Brenda

 

Brenda Killen

Director, Governance

Direct: +41 22 909 66 80

Mobile: +41 79 554 57 04

Web: gavi.org

 

 

NOTICE: This email, including any attachments to it, may be confidential and does not create any binding contract on behalf of Gavi or its partners.

If this email was sent to you in error, please notify the sender immediately by reply e-mail, and please do not use, distribute, retain, print or copy the e-mail or any attachment.